Breast cancer is the most commonly diagnosed cancer in American women and is the second leading cause of cancer-related deaths in this population. This review highlights how the use of a multidisciplinary approach to the management of diseases of the breast and the introduction of novel systemic therapies have improved the quality of life and survival in patients with breast cancer. Clinical Pharmacology & Therapeutics (2008) 83, 26–36; doi:10.1038/sj.clpt.6100449
No takes yet. Share an insight, caveat, or question.
Moulder et al. (2007) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: